Table 2.
Potential therapeutic targets | Extracellular response | Ref. |
K-ras mutant oncogene | Proliferation of desmoplastic reaction (leukocytes, fibroblasts, endothelial cells, neuronal cells, collagen, hyaluron): upregulation of GM-CSF | Chu et al[78]; Neesse et al[79]; Ying et al[81]; Nolan-Stevaux et al[82]; Bayne et al[87] |
Sonic hedgehog (SHH) | Growth and differenatiation of stromal fibroblasts | Bailey et al[83]; Tian et al[84]; Olive et al[85] |
Tumor associated macrophages (TAMs); cancer associated fibroblasts (CAFs); regulatory T-cells (Treg); myeloid derived suppressor cells | Evasion of the immune system | Bayne et al[87]; Pylayeva-Gupta et al[88] |
Desmoplastic reaction | Anti-angiogenesis; hypoxic tumor environment | Komar et al[86] |
K-ras: Kinase-rat sarcoma; GM-CSF: Granulocyte macrophage colon-stimulating factor.